Search research articles
Contact Us
Filters
Showing results (71-80 of 137) with videos related to
Page
of 14
Sort By:
Cancer Biotherapy & Radiopharmaceuticals
|
October 27, 2005
Radioimmunotargeting of human rhabdomyosarcoma using monoclonal antibody 8H9
Shakeel Modak, Hong Fen Guo, John L Humm, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 12, 2009
Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma
Brian H Kushner, Nai-Kong V Cheung, Christopher A Barker, et al.
Pediatric Blood & Cancer
|
November 2, 2007
Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy
Shakeel Modak, Neeta Pandit-Taskar, Brian H Kushner, et al.
Pediatric Blood & Cancer
|
July 31, 2021
Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma
Sanam Shahid, Brian H Kushner, Shakeel Modak, et al.
International Journal of Cancer
|
August 1, 2022
Immunotherapy with anti-G<sub>D2</sub> monoclonal antibody in infants with high-risk neuroblastoma
Brian H Kushner, Shakeel Modak, Kim Kramer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2004
Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors
Shakeel Modak, Sharon Gardner, Ira J Dunkel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 9, 2010
Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma
Victoria J Croog, Kim Kramer, Nai-Kong V Cheung, et al.
Cancers
|
December 24, 2021
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma
Fiorella Iglesias Cardenas, Audrey Mauguen, Irene Y Cheung, et al.
JAMA Oncology
|
December 22, 2022
Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical Trial
Irene Y Cheung, Audrey Mauguen, Shakeel Modak, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 15, 2018
Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?
Dana L Casey, Ken L Pitter, Brian H Kushner, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 137) with videos related to
Sort By:
Page
of 14
Cancer Biotherapy & Radiopharmaceuticals
|
October 27, 2005
Radioimmunotargeting of human rhabdomyosarcoma using monoclonal antibody 8H9
Shakeel Modak, Hong Fen Guo, John L Humm, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 12, 2009
Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma
Brian H Kushner, Nai-Kong V Cheung, Christopher A Barker, et al.
Pediatric Blood & Cancer
|
November 2, 2007
Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy
Shakeel Modak, Neeta Pandit-Taskar, Brian H Kushner, et al.
Pediatric Blood & Cancer
|
July 31, 2021
Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma
Sanam Shahid, Brian H Kushner, Shakeel Modak, et al.
International Journal of Cancer
|
August 1, 2022
Immunotherapy with anti-G<sub>D2</sub> monoclonal antibody in infants with high-risk neuroblastoma
Brian H Kushner, Shakeel Modak, Kim Kramer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2004
Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors
Shakeel Modak, Sharon Gardner, Ira J Dunkel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 9, 2010
Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma
Victoria J Croog, Kim Kramer, Nai-Kong V Cheung, et al.
Cancers
|
December 24, 2021
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma
Fiorella Iglesias Cardenas, Audrey Mauguen, Irene Y Cheung, et al.
JAMA Oncology
|
December 22, 2022
Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical Trial
Irene Y Cheung, Audrey Mauguen, Shakeel Modak, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 15, 2018
Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?
Dana L Casey, Ken L Pitter, Brian H Kushner, et al.
Page
of 14